An interventional study of Patient counselling in Cardiovascular Diseases, Heart Diseases and Cerebrovascular Disease, sponsored by University Hospital, Ioannina. Recruiting at 1 site in Greece. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-02.
Sponsored by University Hospital, Ioannina · Not applicable, Interventional, and Prevention
The North Kynouria Project was initiated to study cardiovascular/stroke risk factors by employing mass screening and long-term surveillance of an adult population in the municipality of North Kynouria, in the county of Arcadia, Peloponnese, Greece. The North Kynouria Study was initiated to assess modifiable and non-modifiable determinants of cerebrovascular and coronary heart disease.
BACKGROUND:
The North Kynouria Project is a longitudinal, interventional-behavioural, prospective study aiming to identify cardiovascular/stroke risk factors, in the adult population of the municipality of North Kynouria, in the county of Arcadia, Peloponnese, Greece. The project, initiated in November 2022, recruits volunteers, of both sexes, over 18 years of age, irrespective of their personal history of cardiovascular disease. The epidemiology and burden of cardiovascular disease in North Kynouria remain unknown. The study aims to explore and document the prevalence of major cardiovascular/stroke risk factors, as well as the nutritional status, cigarette smoking, exercise habits, alcohol consumption, and overall quality of life of the inhabitants.
DESIGN NARRATIVE:
The screening exam is conducted at the Astros, Health Center, by obtaining the patient's personal history, and information about the patient's habits, such as physical activity, smoking, and alcohol consumption. Body weight, height, and waist-to-hip ratio are also measured. During the examination, blood pressure is evaluated using a pre-specified protocol, including assessment of orthostatic hypertension. Further testing includes electrocardiography, ankle-brachial index, direct ophthalmoscopy, and carotid and cardiac ultrasound. Blood samples are collected and stored at the deep freeze of the Astros premises, and blood count, lipid panel, and liver and kidney function are measured.
The main field of interest is the prevalence and burden of risk factors and cardiovascular disease in the wider region of North Kynouria, Arcadia Greece. The project aims to assess the epidemiology of CVD and consequently improve public health and engage with the local community through healthy behavioral education.
5,368 studies on the registry are indexed under Cardiovascular Diseases; 939 are open to participants now.
This study's planned enrollment of 7,000 is above the median of 100 across 3,084 interventional studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →University Hospital, Ioannina is the lead sponsor of 13 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Single group, no masking, receiving the intervention
Behavioral: Patient counselling
Patient counseling, lifestyle modifications, medication evaluation, and adherence
Also known as: lifestyle modifications, dietary recommendations, smoking cessation, physical activity recommendations, medication adherence
Major adverse cardiovascular events
myocardial infarction, ischemic and hemorrhagic stroke
Time frame: up to 5 years after enrollment
All-cause mortality
Death by any cause, cardiovascular, infection, cancer, other
Time frame: up to 5 years after enrollment
Hospitalizations
Any cause hospitalization
Time frame: up to 5 years after enrollment
Emergency room visits
Any cause of emergency room visit
Time frame: up to 5 years after enrollment
New diagnosis of Arterial hypertension
Any diagnosis of arterial hypertension, masked, white-coat, nocturnal
Time frame: up to 1 year after enrollment
New diagnosis of diabetes mellitus
Type 1 or Type 2
Time frame: up to 1 year after enrollment
New diagnosis of dyslipidemia
New diagnosis or uncontrolled
Time frame: up to 1 year after enrollment
New diagnosis of carotid atherosclerosis
Evaluation of carotid artery stenosis
Time frame: up to 1 year after enrollment
New diagnosis of peripheral artery disease
Ankle Brachial Index evaluation
Time frame: up to 1 year after enrollment
Plan to share: Yes — Study protocol details
Supporting information: Study protocol
Time frame: 2024-2025
Access criteria: Through access granting from the University of Ioannina
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Ioannina